About JASMIN Society
Established as a venue for information exchange, JASMIN Society pursues the dual approaches of (1) basic research and (2) clinical research into the discovery and application of the novel actions of sirolimus.
"JASMIN Society" is an abbreviation for "Japanese Association of Sirolimus Medical Investigation Network."
JASMIN Society supports the expansion of sirolimus use for new diseases and the regulatory approval of sirolimus for new administrations and dosages.
It further seeks to enlighten healthcare practitioners in multiple fields about the side effects of sirolimus and to educate young researchers engaged in basic and clinical research involving sirolimus. We are working to deepen an understanding of the pharmacological actions of sirolimus, to share clinical information obtained from research, including information on efficacy and side effects, with researchers and clinicians, and to contribute to the improvement of future medical care.
The website offers members-only pages as a means for members to exchange information.
Registering members can participate in web-based discussions.
(Use of the members-only pages requires separate membership registration via the site.)
The members-only section accepts questions concerning research and inquiries concerning dosage and side effects in off-label use from medical practitioners who are using or considering the use of sirolimus.
We invite you to make use of these resources.
About membership
The following individuals and groups are eligible for membership.
- Physicians or researchers who have knowledge of and experience in sirolimus research and related disciplines
- University graduates or students who have academic knowledge of sirolimus research and related disciplines
- Healthcare practitioners who have academic background and experience in sirolimus research and related disciplines
- Other parties recognized by the Officers of the Society as equating to any of the above
Members get unlimited free access to the online Forum to participate in web-based discussions. The Forum offers members-only pages as a means for members to exchange information. It accepts questions concerning research and inquiries concerning dosage and side effects in off-label use from medical practitioners using or considering the use of sirolimus.
To request membership, please read the Rules of the Society and click the banner to make an inquiry.
Contact information
■JASMIN Society Secretariat
1-757 Asahimachidori, Chuo-ku, Niigata 951-8510
Center for Medical Innovation Division of Pioneering Advanced Therapeutics, Niigata University Medical & Dental Hospital
JASMIN Society Officers
Chairman
- Toshinori TakadaUonuma Institute of Community Medicine, Niigata University Medical & Dental Hospital
Vice Chairman
- Nobuyuki TakeiDepartment of Brain Tumor Biology, Basic Neuroscience Branch, Niigata University Brain Research Institute
Governors
- Michio KosekiPediatric Pathology, Department of Pediatrics, Graduate School of Medicine, Gifu University
- Akifumi EndoClinical Research Center, Medical Hospital, Tokyo Medical & Dental University
- Masaru SuzukiCourse of Respiratory Medicine, Department of Internal Medicine, Graduate School of Medicine, Hokkaido University
- Hirokazu NakatsumiDepartment of Molecular Biology, Graduate School of Pharmaceutical Sciences, Nagoya City University
Accounting Auditor
- Koh NakataCenter for Medical Innovation Division of Pioneering Advanced Therapeutics, Niigata University Medical & Dental Hospital